A depression treatment known as transcranial magnetic stimulation or TMS for short in English, was recently apoB in the United States. This treatment is to induce a small current Power in the brain by releasing a tool magnetic pulses through the skull. These electrical currents excite the nerve cells or neurons, thus triggering brain activity. The magnetic pulses are directed to the prefrontal region of the brain with the idea of \u200b\u200bdeveloping a chain reaction that reaches to stimulate deep brain regions, particularly the one known as the limbic system, believed to be primarily responsible for controlling our moods.
transcranial magnetic stimulation is a noninvasive procedure that typically takes place in sessions lasting between 30 and 45 minutes and requires no anesthesia or hospitalization. Treatments are usually held five times a week for a minimum of ten sessions. In some cases it takes up to 30 sessions before achieving positive results. To our knowledge the treatment seems very risky. In a study conducted with the equipment approved by the FDA called NeuroStar that the company is manfactured Neuronetics Inc., is not found to cause memory loss or seizures, effects that may be caused by ECT. The main side effect of TMS appears to be a headache. Its main disadvantage is the large number of sessions needed for a short period and the cost which is believed can reach ten thousand dollars some cases.
So far, in the United States this treatment has been approved only for people with depression who have not responded to at least one treatment with antidepressants. These people can offer this new option rather than the traditional option of changing the medication to find one that is effective.
patients in this group of studies seem to demonstrate that transcranial magnetic stimulation can help. In one study 24 percent of patients had not responded to initial treatment with an antidepressant medication responded to this new therapy after six weeks of treatment. However, there are questions about how the results have been interpreted. The National Institutes of Health in the United States are at present conducting an independent study which follows up on 260 patients whose initial results could be available in 2009.
0 comments:
Post a Comment